The public sector should pay if EU demands efficient removal of pharmaceuticals from wastewaters, according to researchers at the Center for Antibiotic Research, CARe, at the University of Gothenburg. Their argumentation ...
Sep 5, 2023
0
1
The FAIRplus consortium, including EMBL-EBI and pharmaceutical companies, has launched a new framework to help organizations make their data FAIR.
Jun 29, 2023
0
2
Between 2018–19 and 2019–20, spending on mental and substance use disorders grew to replace injuries as the fourth highest category of health spending.
Dec 2, 2022
0
2
In an interconnected world, a pandemic can be overcome only when it is overcome everywhere—no one is safe until everyone is safe. Vaccination delays and supply shortages in protective equipment and treatments increase the ...
Feb 15, 2022
0
6
As the world rushes to identify safe and effective vaccines and therapeutics to counter the COVID-19 epidemic, attention is turning to the next step: manufacturing these products at enormous scale.
Aug 14, 2020
0
0
To date, Congress has authorized roughly $3 trillion in COVID-19 relief assistance—the largest relief package in history. With more COVID relief money on the way, a new study led by two Brigham Young University business ...
Aug 12, 2020
0
6
Critics of the pharmaceutical industry say it is misaligned with public interest. So is it time to nationalise the sector? Experts debate the issue in The BMJ today.
Mar 4, 2020
1
161
Large pharmaceutical companies are more profitable than most companies in the S&P 500 according to a study published in the Journal of the American Medical Association (JAMA) titled "Profitability of Large Pharmaceutical ...
Mar 3, 2020
0
8
The World Health Organization's member states adopted on Tuesday a watered down resolution on improving drug price transparency that leading medical charity Doctors Without Borders (MSF) criticised as insufficient.
May 28, 2019
0
1
The pharmaceuticals sector is facing an intensive period of mergers and acquisitions in the coming years, even if US firms Pfizer and Allergan recently failed to tie the knot, the corporate consultancy firm EY said Monday.
May 30, 2016
0
3
